Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305, USA.
Nature. 2012 Dec 20;492(7429):387-92. doi: 10.1038/nature11701. Epub 2012 Dec 9.
Protease-activated receptor 1 (PAR1) is the prototypical member of a family of G-protein-coupled receptors that mediate cellular responses to thrombin and related proteases. Thrombin irreversibly activates PAR1 by cleaving the amino-terminal exodomain of the receptor, which exposes a tethered peptide ligand that binds the heptahelical bundle of the receptor to affect G-protein activation. Here we report the 2.2 Å resolution crystal structure of human PAR1 bound to vorapaxar, a PAR1 antagonist. The structure reveals an unusual mode of drug binding that explains how a small molecule binds virtually irreversibly to inhibit receptor activation by the tethered ligand of PAR1. In contrast to deep, solvent-exposed binding pockets observed in other peptide-activated G-protein-coupled receptors, the vorapaxar-binding pocket is superficial but has little surface exposed to the aqueous solvent. Protease-activated receptors are important targets for drug development. The structure reported here will aid the development of improved PAR1 antagonists and the discovery of antagonists to other members of this receptor family.
蛋白酶激活受体 1(PAR1)是 G 蛋白偶联受体家族的典型成员,该家族介导细胞对凝血酶和相关蛋白酶的反应。凝血酶通过切割受体的氨基末端外显子不可逆地激活 PAR1,从而暴露一个连接的肽配体,该配体结合受体的七螺旋束以影响 G 蛋白的激活。在这里,我们报告了与人 PAR1 结合的 vorapaxar 的 2.2Å 分辨率晶体结构,vorapaxar 是一种 PAR1 拮抗剂。该结构揭示了一种不寻常的药物结合模式,解释了小分子如何几乎不可逆地结合以抑制 PAR1 的连接配体对受体激活的作用。与在其他肽激活的 G 蛋白偶联受体中观察到的深、溶剂暴露的结合口袋不同,vorapaxar 的结合口袋虽然很浅,但与水溶剂的暴露表面很少。蛋白酶激活受体是药物开发的重要靶点。这里报道的结构将有助于开发改进的 PAR1 拮抗剂和发现该受体家族其他成员的拮抗剂。